Enstar Group Ltd
Change company Symbol lookup
Select an option...
ESGR Enstar Group Ltd
HCFT Hunt Companies Finance Trust Inc
BHV BlackRock Virginia Municipal Bond Trust
JNJ Johnson & Johnson
TRQ Turquoise Hill Resources Ltd
STAA STAAR Surgical Co
PRPL Purple Innovation Inc
INTC Intel Corp
PSB PS Business Parks Inc
GWRE Guidewire Software Inc
Go

Financials : Insurance | Small Cap Growth
Based in Bermuda
Company profile

Enstar Group Limited is an insurance group that offers capital release solutions and specialty underwriting capabilities through its network of group companies in Bermuda, the United States, the United Kingdom, Continental Europe, Australia and other international locations. The Company's segments include Non-Life Run-Off, Atrium, StarStone, and Life and Annuities. The Non-life Run-off segment comprises the operations of its subsidiaries that are running off their property and casualty and other non-life lines of business. The Atrium segment underwrites specialist marine, energy, aerospace, non-marine and liability classes. The StarStone segment offers a range of property, casualty and specialty insurance products. The Life and Annuities Segment consists of the operations managing the Company's closed-block of life and annuity business, and its life settlements business.

Closing Price
$178.50
Day's Change
0.92 (0.52%)
Bid
--
Ask
--
B/A Size
--
Day's High
180.87
Day's Low
178.02
Volume
(Heavy Day)
Volume:
43,938

10-day average volume:
30,446
43,938

Moore Kuehn Encourages SBPH, PFNX, VAR, and PRNB Investors to Contact Law Firm

1:16 pm ET September 9, 2020 (Globe Newswire) Print

Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies:

-- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH)

A registration statement was recently filed with the SEC regarding F-star Therapeutics' acquisition of Spring Bank Pharmaceuticals. Upon completion of the merger, shareholders of Spring Bank will only own approximately 38.8% of the combined company. The investigation concerns whether Spring Bank's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price.

-- Pfenex Inc. (NYSE: PFNX)

A solicitation statement was recently filed with the SEC regarding Ligand Pharmaceuticals' acquisition of Pfenex, which may omit material information regarding the financial metrics and analyses used to evaluate the merger. Under the proposed transaction, shareholders of Pfenex will receive $12.00 in cash for every share owned.

-- Varian Medical Systems, Inc. (NYSE: VAR)

A registration statement was recently filed with the SEC regarding affiliates of Siemens Healthineers AG's acquisition of Varian Medical. Upon completion of the merger, shareholders of Varian Medical will receive $177.50 in cash for every share owned. The investigation concerns whether Varian's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price.

-- Principia Biopharma Inc. (NASDAQ: PRNB)

A registration statement was recently filed with the SEC regarding Sanofi's acquisition of Principia Biopharma, which may omit material information regarding the financial metrics and analyses used to evaluate the merger. Upon completion of the merger, shareholders of Principia Biopharma will receive $100.00 in cash for every share owned.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.

Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com or telephone at (212) 709-8245. The consultation and case are free with no obligation to you. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Moore Kuehn is a 5-star New York City-based law firm with attorneys representing investors and consumers in class action litigation involving securities law violations, financial fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please go to http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:

Moore Kuehn, PLLC

Justin Kuehn, Esq.

30 Wall Street, 8 Floor

New York, New York 10005

jkuehn@moorekuehn.com

(212) 709-8245

https://ml.globenewswire.com/media/d193dca2-d2bd-436c-84ad-702f7e967f18/small/moorekuehn-1-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.